KOS-1584

DB05903

small molecule investigational

Deskripsi

KOS-1584 is a second-generation epothilone. Epothilones are anticancer agents with a taxane-like mechanism of action that have demonstrated activity in taxane-resistant tumors. KOS-1584 is a second-generation compound with increased potency, favorable tissue distribution, and ease of formulation.

Struktur Molekul 2D

Berat 489.67
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

321 Data
Eliglustat The metabolism of Eliglustat can be decreased when combined with KOS-1584.
Ibrutinib The metabolism of Ibrutinib can be decreased when combined with KOS-1584.
Alfentanil The serum concentration of Alfentanil can be increased when it is combined with KOS-1584.
Buspirone The metabolism of Buspirone can be decreased when combined with KOS-1584.
Carbamazepine The metabolism of Carbamazepine can be decreased when combined with KOS-1584.
Cisapride The serum concentration of Cisapride can be increased when it is combined with KOS-1584.
Disopyramide KOS-1584 may increase the QTc-prolonging activities of Disopyramide.
Estazolam The serum concentration of Estazolam can be increased when it is combined with KOS-1584.
Quinine The serum concentration of Quinine can be increased when it is combined with KOS-1584.
Quinidine The serum concentration of Quinidine can be increased when it is combined with KOS-1584.
Repaglinide The serum concentration of Repaglinide can be increased when it is combined with KOS-1584.
Sirolimus The metabolism of Sirolimus can be decreased when combined with KOS-1584.
Temsirolimus The metabolism of Temsirolimus can be decreased when combined with KOS-1584.
Terfenadine The serum concentration of Terfenadine can be increased when it is combined with KOS-1584.
Triazolam The serum concentration of Triazolam can be increased when it is combined with KOS-1584.
Cilostazol The metabolism of Cilostazol can be decreased when combined with KOS-1584.
Colchicine The metabolism of Colchicine can be decreased when combined with KOS-1584.
Iloperidone The metabolism of Iloperidone can be decreased when combined with KOS-1584.
Retapamulin The metabolism of Retapamulin can be decreased when combined with KOS-1584.
Tofacitinib The metabolism of Tofacitinib can be decreased when combined with KOS-1584.
Vardenafil The metabolism of Vardenafil can be decreased when combined with KOS-1584.
Eszopiclone The metabolism of Eszopiclone can be decreased when combined with KOS-1584.
Zopiclone The metabolism of Zopiclone can be decreased when combined with KOS-1584.
Lovastatin The metabolism of Lovastatin can be decreased when combined with KOS-1584.
Alfuzosin The metabolism of Alfuzosin can be decreased when combined with KOS-1584.
Alprazolam The serum concentration of Alprazolam can be increased when it is combined with KOS-1584.
Warfarin The serum concentration of Warfarin can be increased when it is combined with KOS-1584.
Acenocoumarol The serum concentration of Acenocoumarol can be increased when it is combined with KOS-1584.
(R)-warfarin The serum concentration of (R)-warfarin can be increased when it is combined with KOS-1584.
R,S-Warfarin alcohol The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with KOS-1584.
S,R-Warfarin alcohol The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with KOS-1584.
(S)-Warfarin The serum concentration of (S)-Warfarin can be increased when it is combined with KOS-1584.
Midazolam The serum concentration of Midazolam can be increased when it is combined with KOS-1584.
Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with KOS-1584.
Telaprevir The serum concentration of Telaprevir can be increased when it is combined with KOS-1584.
Picosulfuric acid The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with KOS-1584.
Vintafolide The serum concentration of Vintafolide can be increased when it is combined with KOS-1584.
Vincamine The serum concentration of Vincamine can be increased when it is combined with KOS-1584.
Acetyldigitoxin The serum concentration of Acetyldigitoxin can be increased when it is combined with KOS-1584.
Deslanoside The serum concentration of Deslanoside can be increased when it is combined with KOS-1584.
Ouabain The serum concentration of Ouabain can be increased when it is combined with KOS-1584.
Oleandrin The serum concentration of Oleandrin can be increased when it is combined with KOS-1584.
Cymarin The serum concentration of Cymarin can be increased when it is combined with KOS-1584.
Proscillaridin The serum concentration of Proscillaridin can be increased when it is combined with KOS-1584.
Metildigoxin The serum concentration of Metildigoxin can be increased when it is combined with KOS-1584.
Lanatoside C The serum concentration of Lanatoside C can be increased when it is combined with KOS-1584.
Gitoformate The serum concentration of Gitoformate can be increased when it is combined with KOS-1584.
Acetyldigoxin The serum concentration of Acetyldigoxin can be increased when it is combined with KOS-1584.
Peruvoside The serum concentration of Peruvoside can be increased when it is combined with KOS-1584.
Cyclosporine The metabolism of Cyclosporine can be decreased when combined with KOS-1584.
Dicoumarol The serum concentration of Dicoumarol can be increased when it is combined with KOS-1584.
Phenindione The serum concentration of Phenindione can be increased when it is combined with KOS-1584.
Coumarin The serum concentration of Coumarin can be increased when it is combined with KOS-1584.
Tioclomarol The serum concentration of Tioclomarol can be increased when it is combined with KOS-1584.
Ethyl biscoumacetate The serum concentration of Ethyl biscoumacetate can be increased when it is combined with KOS-1584.
Diphenadione The serum concentration of Diphenadione can be increased when it is combined with KOS-1584.
4-hydroxycoumarin The serum concentration of 4-hydroxycoumarin can be increased when it is combined with KOS-1584.
Fluindione The serum concentration of Fluindione can be increased when it is combined with KOS-1584.
Clorindione The serum concentration of Clorindione can be increased when it is combined with KOS-1584.
Oxtriphylline The metabolism of Oxtriphylline can be decreased when combined with KOS-1584.
Doxofylline The metabolism of Doxofylline can be decreased when combined with KOS-1584.
Bamifylline The metabolism of Bamifylline can be decreased when combined with KOS-1584.
Acefylline The metabolism of Acefylline can be decreased when combined with KOS-1584.
Bufylline The metabolism of Bufylline can be decreased when combined with KOS-1584.
Fenethylline The metabolism of Fenethylline can be decreased when combined with KOS-1584.
Proxyphylline The metabolism of Proxyphylline can be decreased when combined with KOS-1584.
Bromotheophylline The metabolism of Bromotheophylline can be decreased when combined with KOS-1584.
Pentoxifylline The metabolism of Pentoxifylline can be decreased when combined with KOS-1584.
8-azaguanine The metabolism of 8-azaguanine can be decreased when combined with KOS-1584.
7,9-Dimethylguanine The metabolism of 7,9-Dimethylguanine can be decreased when combined with KOS-1584.
Xanthine The metabolism of Xanthine can be decreased when combined with KOS-1584.
7-Deazaguanine The metabolism of 7-Deazaguanine can be decreased when combined with KOS-1584.
Guanine The metabolism of Guanine can be decreased when combined with KOS-1584.
9-Methylguanine The metabolism of 9-Methylguanine can be decreased when combined with KOS-1584.
Peldesine The metabolism of Peldesine can be decreased when combined with KOS-1584.
Hypoxanthine The metabolism of Hypoxanthine can be decreased when combined with KOS-1584.
9-Deazaguanine The metabolism of 9-Deazaguanine can be decreased when combined with KOS-1584.
Valomaciclovir The metabolism of Valomaciclovir can be decreased when combined with KOS-1584.
3-isobutyl-1-methyl-7H-xanthine The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with KOS-1584.
Uric acid The metabolism of Uric acid can be decreased when combined with KOS-1584.
6-O-benzylguanine The metabolism of 6-O-benzylguanine can be decreased when combined with KOS-1584.
Lisofylline The metabolism of Lisofylline can be decreased when combined with KOS-1584.
Lobucavir The metabolism of Lobucavir can be decreased when combined with KOS-1584.
Cafedrine The metabolism of Cafedrine can be decreased when combined with KOS-1584.
Theodrenaline The metabolism of Theodrenaline can be decreased when combined with KOS-1584.
Etamiphylline The metabolism of Etamiphylline can be decreased when combined with KOS-1584.
Pentifylline The metabolism of Pentifylline can be decreased when combined with KOS-1584.
Furafylline The metabolism of Furafylline can be decreased when combined with KOS-1584.
Theobromine The metabolism of Theobromine can be decreased when combined with KOS-1584.
Propentofylline The metabolism of Propentofylline can be decreased when combined with KOS-1584.
Caffeine The metabolism of Caffeine can be decreased when combined with KOS-1584.
8-chlorotheophylline The metabolism of 8-chlorotheophylline can be decreased when combined with KOS-1584.
Mercaptopurine The metabolism of Mercaptopurine can be decreased when combined with KOS-1584.
PCS-499 The metabolism of PCS-499 can be decreased when combined with KOS-1584.
Methylergometrine The serum concentration of Methylergometrine can be increased when it is combined with KOS-1584.
Lisuride The serum concentration of Lisuride can be increased when it is combined with KOS-1584.
Nicergoline The serum concentration of Nicergoline can be increased when it is combined with KOS-1584.
Ergoloid mesylate The serum concentration of Ergoloid mesylate can be increased when it is combined with KOS-1584.
Pergolide The serum concentration of Pergolide can be increased when it is combined with KOS-1584.
Ergometrine The serum concentration of Ergometrine can be increased when it is combined with KOS-1584.

Referensi & Sumber

Artikel (PubMed)
  • PMID: 18197722
    Pronzato P: New therapeutic options for chemotherapy-resistant metastatic breast cancer: the epothilones. Drugs. 2008;68(2):139-46.
  • PMID: 17656562
    Fumoleau P, Coudert B, Isambert N, Ferrant E: Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analogues. Ann Oncol. 2007 Jul;18 Suppl 5:v9-15.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul